Whereas our previous model focused on identifying shared biological mechanisms, this study advances the methodology toward comparative drug effectiveness analysis, ranking therapies according to their predicted modulation of pathways central to DM2AD comorbidity formation
The Journal of Nutrition, 138 (8), 1572S-1577S
GSH and similar antioxidant enzymes are lower in the blood of patients with MDD compared to controls, suggesting that there is an effect of GSH in the pathology of MDD (Maes et al
Understanding this distinction is crucial because insurance companies, including Aetna, look at these drugs very differently depending on what they're prescribed for
However, the recent usage of your paper's results makes me comment here, which actually pertains to public health
If youre considering stopping Ozempic, talk to your doctor about how to transition safely